ScRNA-seq analysis has identified a CXCL14 + fibroblast cluster in immunotherapy-responsive RCC patients, suggesting that fibroblasts may influence mechanisms of immunotherapy response [470]. Here, CXCL14 is linked to renal cell carcinoma.